Baykız, D. Et Al. 2022. Galectin-3 as a Novel Biomarker for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients. CLINICAL LABORATORY , vol.68, no.12 , 2483-2495.

Baykız, D., Emet, S., Ayduk-Govdeli, E., Kaytaz, A. M., Yavuz, M., Karaca Özer, P., ... Karaayvaz, E. B.(2022). Galectin-3 as a Novel Biomarker for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients. CLINICAL LABORATORY , vol.68, no.12, 2483-2495.

Baykız, Derya Et Al. "Galectin-3 as a Novel Biomarker for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients," CLINICAL LABORATORY , vol.68, no.12, 2483-2495, 2022

Baykız, Derya Et Al. "Galectin-3 as a Novel Biomarker for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients." CLINICAL LABORATORY , vol.68, no.12, pp.2483-2495, 2022

Baykız, D. Et Al. (2022) . "Galectin-3 as a Novel Biomarker for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients." CLINICAL LABORATORY , vol.68, no.12, pp.2483-2495.

@article{article, author={Derya BAYKIZ Et Al. }, title={Galectin-3 as a Novel Biomarker for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients}, journal={CLINICAL LABORATORY}, year=2022, pages={2483-2495} }